Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors
Abstract
No abstract availableKeywords
Funding Information
- Defense Threat Reduction Agency (1321195)
This publication has 31 references indexed in Scilit:
- A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of actionChemical Communications, 2011
- Basic Tetrapeptides as Potent Intracellular Inhibitors of Type A Botulinum Neurotoxin Protease ActivityJournal of Biological Chemistry, 2011
- Small Molecules Showing Significant Protection of Mice against Botulinum Neurotoxin Serotype APLOS ONE, 2010
- Synthesis and Biological Evaluation of Botulinum Neurotoxin A Protease InhibitorsJournal of Medicinal Chemistry, 2010
- The identification and biochemical characterization of drug-like compounds that inhibit botulinum neurotoxin serotype A endopeptidase activityToxicon, 2009
- Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A’s zinc endopeptidaseBioorganic & Medicinal Chemistry Letters, 2009
- Identification and Biochemical Characterization of Small-Molecule Inhibitors ofClostridium botulinumNeurotoxin Serotype AAntimicrobial Agents and Chemotherapy, 2009
- Use of a Recombinant Fluorescent Substrate with Cleavage Sites for All Botulinum Neurotoxins in High-Throughput Screening of Natural Product Extracts for Inhibitors of Serotypes A, B, and EApplied and Environmental Microbiology, 2008
- Human Botulism Immune Globulin for the Treatment of Infant BotulismNew England Journal of Medicine, 2006
- Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activityFEBS Letters, 1998